ARTELO BIOSCIENCES INC (ARTL:NASDAQ)

$1.08 0.06 (5.8824%)

watchlist-icon
search-icon
Profile Icon

Most Recent Average Sentiment Analysis Score (0 to 100): 74

negative-sentiment
Negative [0, 35)
neutral-sentiment
Neutral [35, 65]
positive-sentiment
Positive (65, 100]
Visualize Sentiment Trendline

Analysed ARTELO BIOSCIENCES INC (ARTL:NASDAQ) News Sources

Artelo Biosciences Announces $11.0 Million Private Placement Priced At-the-Market Under Nasdaq Rules

27-03-2026

yahoo.com

Artelo Biosciences Announces Closing of $11.0 Million Private Placement Priced At-the-Market Under Nasdaq Rules

30-03-2026

yahoo.com

Artelo Biosciences Regains Compliance with Nasdaq Listing Requirements

07-04-2026

yahoo.com

Artelo Announces Peer-Reviewed Publication Supporting its FABP5 Inhibitor ART26.12 as a Novel Pain Treatment with a Potentially First-in-Class Profile

20-04-2026

yahoo.com

Artelo Biosciences Announces Strategic Collaboration with Artificial Intelligence (AI) Leader ScienceMachine Highlighting New Expansion Opportunities and Insights for FABP5 Inhibitor Development

28-04-2026

yahoo.com

Artelo Biosciences Provides Business Update Outlining Upcoming Milestones and Reports 2026 First Quarter Financial Results

14-05-2026

yahoo.com

Artelo Biosciences Presents ART26.12 Human Metabolite Data Demonstrating Favorable Drug Metabolism Characteristics Associated with Clinical Development Success

10-06-2026

yahoo.com

Artelo Biosciences Presents Clinical and Biomarker Data Supportive of the Development of ART26.12 and Follow-On FABP5 Inhibitors at ICRS 2026

29-06-2026

yahoo.com

Artelo Biosciences Presents Evidence for a Common Lipid-Signaling Link Across Multiple Potential Indications for Its FABP5 Inhibitor Platform at ICRS 2026

30-06-2026

yahoo.com

Artelo Biosciences Announces New Data Supporting ART26.12 as a Potential First-in-Class Therapy for Chronic Pain associated with Spinal Cord Injury

01-07-2026

yahoo.com

ARTELO BIOSCIENCES INC (ARTL:NASDAQ) Sentiment Trend

0 25 50 75 100 74 23 71 80 86 86 78 78 83 85 27-03-2026 30-03-2026 07-04-2026 20-04-2026 28-04-2026 14-05-2026 10-06-2026 29-06-2026 30-06-2026 01-07-2026 #1 #2 #3 #4 #5 #6 #7 #8 #9 #10 Negative < 35 Neutral 35–65 Positive > 65 View FAQ

ARTELO BIOSCIENCES INC (ARTL:NASDAQ) FAQs

toggle

What is the current price of ARTELO BIOSCIENCES INC (ARTL:NASDAQ)?

The current price of ARTELO BIOSCIENCES INC (ARTL:NASDAQ) is $1.08.


toggle

ARTELO BIOSCIENCES INC (ARTL:NASDAQ) absolute price change since previous trading day?

The absolute price change of ARTELO BIOSCIENCES INC (ARTL:NASDAQ) since the previous trading day is $0.06.


toggle

ARTELO BIOSCIENCES INC (ARTL:NASDAQ) percentage price change since previous trading day?

The percentage price change of ARTELO BIOSCIENCES INC (ARTL:NASDAQ) since the previous trading day is 5.8824%.


toggle

What is the most recent average sentiment score for ARTELO BIOSCIENCES INC (ARTL:NASDAQ)?

The most recent average sentiment score for ARTELO BIOSCIENCES INC (ARTL:NASDAQ) is 74 out of 100.


toggle

What is the most recent average sentiment for ARTELO BIOSCIENCES INC (ARTL:NASDAQ)?

The most recent sentiment for ARTELO BIOSCIENCES INC (ARTL:NASDAQ) is .


SEC-8K** Filing Available For ARTELO BIOSCIENCES INC (ARTL:NASDAQ)

** material developments that could impact a company's financial condition or stock price.

Author: MattELab

X Icon

GitHub Icon

MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.